Demystifying Pharmacogenomics

If the term ‘Pharmacogenomics’ is new to you or you want to learn more about this – this webinar series is for you! 

We bring experts together from all around Great Britain to give you an insight into how PGx is developing and the impact this will have on patient safety across all sectors, including when it’s likely to impact your day-to-day practice. 

During this first session of the series, we give you an insight into what PGx is, an update from England, Scotland and Wales and what this means for pharmacy going forward.

Speakers: 

  • Sophie Harding - Pharmacogenomics Lead, RPS
  • Dr Alexandra Murray - Consultant Clinical Geneticist and Clinical Director, All Wales Medical Genomics Service
  • Professor Zosia Miedzybrodzka - Professor of Medical Genetics, University of Aberdeen
  • Professor Kate Tatton-Brown - Consultant Clinical Geneticist, St George’s University Hospitals NHS Foundation Trust. Clinical Director and Head of the Genomics Education Programme, Health Education England
  • Fleur Van Gelder - Community Pharmacist, Leiden, Netherlands

Resources: